全球骨生物製藥市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計整形外科生物製劑市場將從 2025 年的 81.1 億美元成長到 2034 年的 139.6 億美元，2026 年至 2034 年的複合年成長率為 6.21%。

隨著再生醫學在肌肉骨骼治療中日益重要，整形外科生物製劑市場正經歷快速成長。源自天然材料的整形外科生物製劑，例如骨移植、富血小板血漿和幹細胞療法，正被擴大用於促進癒合、增強組織再生並縮短整形外科手術後的恢復時間。運動傷害、骨關節炎和創傷相關疾病發生率的上升，推動了對這些先進治療方法的需求。

未來的成長將得益於生物材料、3D列印和生物工程支架領域的突破性進展，這些進展將改善組織整合和長期功能。研究方向著重於開發具有更高生物活性和可控釋放機制的新一代整形外科生物製劑，以確保更有效的治療效果。整形外科生物製劑與微創手術技術的結合有望提高手術效率，減少併發症，並促進其在全球整形外科中心的廣泛應用。

對臨床試驗投入的增加以及對創新治療方法的監管支持力度加大，進一步鞏固了市場前景。個人化醫療方法，例如患者特異性移植和個人化細胞療法，正在塑造未來。隨著醫療保健支出的成長和人們對再生醫學解決方案認知的提高，整形外科生物製劑市場有望發展成為先進整形外科醫學的基礎。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球骨生物製藥市場：依產品分類

• 市場分析、洞察與預測
• 去鈣骨基質（DBM）
• 羥基磷灰石（HAp）
• 透明質酸（HA）
• 硫酸鈣基質
• AZA2-磷酸三鈣（AZA2-TCP）
• AZA2-TCP+HAp
• DBM+HA
• AZA2-TCP+PLGA
• 再生醫學
• 生長因子

第5章 全球骨生物製藥市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 整形外科診所
• 其他（耳鼻喉科診所等）

第6章 全球骨生物製藥市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Arthrex Inc
  • ATEC Spine Inc
  • Bioventus
  • Exactech Inc
  • Globus Medical
  • Integra Lifesciences Corporation
  • Johnson & Johnson
  • Medtronic Plc
  • MTF Biologics
  • NORAKER
  • RTI Surgical
  • Stryker
  • Zimmer Biomet

The Orthobiologics Market size is expected to reach USD 13.96 Billion in 2034 from USD 8.11 Billion (2025) growing at a CAGR of 6.21% during 2026-2034.

The orthobiologics market is experiencing rapid development as regenerative medicine becomes central to musculoskeletal treatments. Derived from natural substances such as bone grafts, platelet-rich plasma, and stem cell therapies, orthobiologics are being increasingly utilized to accelerate healing, enhance tissue regeneration, and reduce recovery times in orthopedic procedures. Rising incidences of sports injuries, osteoarthritis, and trauma-related conditions are fueling demand for these advanced therapies.

Future growth will be driven by breakthroughs in biomaterials, 3D printing, and bioengineered scaffolds that improve integration and long-term functionality. Research pipelines are focusing on next-generation orthobiologics with higher bioactivity and controlled release mechanisms, ensuring more effective outcomes. The integration of orthobiologics with minimally invasive surgical techniques is expected to enhance procedural efficiency, reduce complications, and expand adoption across orthopedic centers globally.

The market outlook is strengthened by increasing investments in clinical trials and regulatory support for innovative therapies. Personalized medicine approaches, such as patient-specific grafts and tailored cellular therapies, are shaping the future landscape. With rising healthcare expenditures and growing awareness of regenerative solutions, the orthobiologics market is positioned to evolve as a cornerstone of advanced orthopedic care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Demineralized Bone Matrix (DBM)
• Hydroxyapatite (HAp)
• Hyaluronic acid (HA)
• Calcium Sulfate Matrix
• AZA2-tricalcium phosphate (AZA2-TCP)
• AZA2-TCP + HAp
• DBM + HA
• AZA2-TCP + PLGA
• Regenerative medicine
• Growth Factors

By End-user

• Hospitals
• Orthopedic Clinics
• Others (ENT Clinics, etc.)

COMPANIES PROFILED

• Arthrex Inc, ATEC Spine Inc, Bioventus, Exactech Inc, Globus Medical, Integra Lifesciences Corporation, Johnson Johnson, Medtronic plc, MTF Biologics, NORAKER, RTI Surgical, Stryker, Zimmer Biomet
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORTHOBIOLOGICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Demineralized Bone Matrix (DBM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hydroxyapatite (HAp) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Hyaluronic acid (HA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Calcium Sulfate Matrix Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. AZA2-tricalcium phosphate (AZA2-TCP) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. AZA2-TCP + HAp Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. DBM + HA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. AZA2-TCP + PLGA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Regenerative medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Growth Factors Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORTHOBIOLOGICS MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Orthopedic Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others (ENT Clinics, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORTHOBIOLOGICS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End-user
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End-user
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End-user
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End-user
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End-user
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ORTHOBIOLOGICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Arthrex Inc
  • 8.2.2 ATEC Spine Inc
  • 8.2.3 Bioventus
  • 8.2.4 Exactech Inc
  • 8.2.5 Globus Medical
  • 8.2.6 Integra Lifesciences Corporation
  • 8.2.7 Johnson & Johnson
  • 8.2.8 Medtronic Plc
  • 8.2.9 MTF Biologics
  • 8.2.10 NORAKER
  • 8.2.11 RTI Surgical
  • 8.2.12 Stryker
  • 8.2.13 Zimmer Biomet